Skip to main content

Waters Corporation company profile

  • WAT · NYSE
  • Instruments
  • Life Sciences Tools & Services
  • S&P 500
$460.25−0.42%Close 13 Nov 2026

About Waters Corporation

Waters Corporation designs, manufactures, sells and services analytical instruments, chromatography columns and other consumables, and software. Its core products include high-performance and ultra-performance liquid chromatography (LC) systems, mass spectrometry (MS) systems and integrated LC-MS systems, along with post-warranty service plans. Through its TA Instruments product line, the company also offers thermal analysis, rheometry and calorimetry instruments. Following its February 2026 acquisition of the Biosciences and Diagnostic Solutions businesses of Becton, Dickinson and Company, its offerings also include flow cytometry instruments and reagents, and diagnostic products. Customers include pharmaceutical companies, other industrial accounts, and academic and governmental institutions, which together made up the company's 2025 net sales. The company sells and services its products worldwide through 82 sales offices as of December 31, 2025.

A summary of the business section of the company's latest annual report, filed 23 Feb 2026.

Company facts

TickerWAT · NYSE
SectorInstruments
IndustryLife Sciences Tools & Services
IndexS&P 500
Fiscal year ends31 December
Reporting currencyUSD
CIK1000697
Latest annual report10-K, filed 23 Feb 2026

Officers and directors

NameRoleShares ownedLatest Form 4
Udit Batra, Ph.D.President and CEO · Director146K · < 1%Shares withheld for tax, 2 Mar 2026
Christopher A. KueblerDirector35.6K · < 1%Option exercise, 6 Aug 2026
Amol ChaubalSVP & Chief Financial Officer30.4K · < 1%Shares withheld for tax, 12 May 2026
Jianqing BennettSVP Waters Adv. Diagnostics24.4K · < 1%Shares withheld for tax, 6 Apr 2026
Linda BaddourDirector9.8K · < 1%Grant or award, 25 Feb 2026
Pearl S. Huang, Ph.D.Director8.1K · < 1%Grant or award, 25 Feb 2026
Mark P. VergnanoDirector7.2K · < 1%Grant or award, 25 Feb 2026
Wei JiangDirector6.7K · < 1%Grant or award, 30 Jun 2026
Richard FearonDirector5.7K · < 1%Open-market purchase, 6 Mar 2026
Robert CarpioSVP Waters Analytical Sciences2.1K · < 1%Shares withheld for tax, 24 Jun 2026
Heather KnightDirector2.0K · < 1%Grant or award, 30 Jun 2026
Claire M. Fraser, Ph.D.Director489 · < 1%Grant or award, 25 Feb 2026
Brennan Daniel J.Director—Grant or award, 25 Feb 2026
Ornskov FlemmingDirector—Grant or award, 25 Feb 2026

Holdings as the latest proxy statement states them, all forms counted; the latest Form 4 line each filed. People appointed since the proxy are listed from their Form 4 filings.

WAT in the terminal

The business section of every annual report, officers' holdings and trades, and the company's filings as they arrive.